Dr. Ivan Colon, MD

Dr. Colon practices at R&N Anesthesia in Brooklyn, New York.

Dr. Colon's NPI, 1366446825, was assigned on June 11, 2005. Dr. Colon graduated from University of Wisconsin-Madison in 1994. Dr. Colon holds New York license 207895.

Dr. Colon's primary practice is R&N Anesthesia, at 175 Remsen St, Brooklyn, NY 11201 in Kings County. The practice phone is (718) 222-5999.

Dr. Colon's primary practice is R&N Anesthesia in Brooklyn, New York. Dr. Colon is also affiliated with The Brooklyn Hospital Center. The medical group on file is NewYork-Presbyterian Medical Group/Westchester. Dmand AI also links Dr. Colon to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Colon practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Colon's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Colon is board certified in urology by the American Board of Urology. Dmand AI has Dr. Colon's licenses on file in 2 states: New York and California.

Dmand AI lists bladder disease, enlarged prostate, erectile dysfunction, kidney cysts, kidney disease, kidney stone disease, pelvic prolapse and prostate cancer among the conditions Dr. Colon treats.

CMS data shows 3,306 Medicare services from Dr. Colon across 36 procedure codes in 2024, for 480 Medicare patients. Medicare paid $233,345 for them. Every service was in an office.

CMS counts 480 Medicare patients who saw Dr. Colon in 2024. The largest group is 65 to 74, with 221 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Colon's median patient age at 65, with 23% women.

In 2024, Dr. Colon wrote 3,665 Medicare Part D claims for 1,023 patients. 77% of them were for generic drugs. CMS names the drug for 3,544 of them, across 30 drugs with 11 or more claims each, at $2,475,675 in total drug cost. In 2023, CMS named 3,888 claims across 33 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Colon for performance year 2024, reported as part of a group. Dr. Colon accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Colon, published from 2008 to 2015. Dr. Colon has published most often in J Urol. Dr. Colon's most frequent co-authors are Fernando J. Cabrera, MD, Joseph Raymund Feliciano, MD and Michael Nicolo Ferrandino, MD.

CMS Open Payments shows 324 general payments to Dr. Colon from 37 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 54% of the total. Astellas Pharma US Inc paid the most, $21,454.

Dmand AI lists 2 awards for Dr. Colon, most recently CMS Stage 1 2012 in 2011.

Dr. Colon graduated from University of Wisconsin-Madison in 1994.

Dr. Colon is in network with 17 carriers, including Elevance, Aetna and United Healthcare. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.